Latest news for Alternaturals (OTC:ANAS) Stock

Alternaturals Inc is an agricultural technology company. It launches a pollution-free, high-efficiency way of large-scale planting, and provides consumers with the healthiest and safest. Its plant factory uses sensing components, integrating information and communication technology (ICT), Internet of Things (IOT), and data and supplemented by agricultural ERP systems, combined with green energy such as wind and solar energy. Its mission is to provide an environmentally friendly agricultural solution. products.

Alternaturals Inc

WIIM

GE Vernova shares are trading higher after the company raised its FY24 guidance.

Needham analyst Scott Berg reiterates Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) with a Buy and maintains $55 price target.

News

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Sprout Social, Maintains $55 Price Target

Guidance

GE Vernova Raises FY24 Revenue Guidance To Towards Higher End of $34B-$35B Range vs $34.63B Est.; Raises FY24 Adjusted EBITDA Margin Guidance From Higher End of Mid-Single Digits To 5%-7%; Raises FY24 Free Cash Flow Guidance From $0.7B-$1.1B To $1.3B-$1.7B

GE Vernov (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) reported quarterly sales of $8.200 billion which missed the analyst consensus estimate of $8.259 billion by 0.71 percent.

Earnings

Earnings Misses

GE Vernov Q2 Sales $8.2B Miss $8.259B Estimate

GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) shares are trading lower today. The company revealed that EVA Air, following its recent&nbsp;order for four Boeing 787-10 Dreamliners, has also ordered <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39924815/eva-orders-genx-engines-to-power-boeing-787-fleet-expansion" rel="noreferrer noopener">GEnx engines for their new aircraft</a>.
Introduced in 2011, the GEnx engine family has amassed over 56 million flight hours and is GE Aerospace&#8217;s fastest-selling high-thrust engine with nearly 3,000 units in service or backlog.
GE Aerospace announced that American Airlines Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) had finalized an order for 180 CF34-8E engines and spares to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39905619/american-airlines-orders-180-cf34-engines-to-power-new-embraer-175-fleet" rel="noreferrer noopener">power its 90 new Embraer 175 regional jets</a>.
With over 7,500 CF34 engines in use by 900+ operators worldwide, the CF34-8E has logged over 40 million flight hours and 29 million cycles since 2004. The CF34 family, including -3, -8, and -10 models, powers over 2,500 regional aircraft.
GE Aerospace has delivered nearly 11,000 CF34 engines, boasting a 99.97% dispatch reliability rate over the past year and compatibility with approved SAF fuel blends.
Yesterday, GE Aerospace reported&nbsp;second-quarter 2024 adjusted revenue growth of 4% year-over-year to $8.22 billion, missing the <a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/39906980/ge-aerospace-reports-mixed-q2-results-raises-full-year-profit-and-cash-flow-guidance" rel="noreferrer noopener">consensus of $8.462 billion</a>.
The company witnessed total orders growth of 18% Y/Y to $11.2 billion, with Commercial Engines &amp; Services +38% and Defense &amp; Propulsion Technologies -25%.
Also, this week, GE Aerospace teamed up with Oak Ridge to enhance supercomputing for next-gen <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39880146/ge-aerospace-invests-in-supercomputing-talent-plans-to-hire-900-engineers" rel="noreferrer noopener">aircraft engine tech like Open Fan</a>.
The company plans to hire over 900 engineers in 2024 to drive innovation and support both current engine programs and future flight technologies.
Investors can gain exposure to the stock via IShares U.S. Aerospace &amp; Defense ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>)&nbsp;and TCW Transform Systems ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NETZ#NYSE">NETZ</a>).
Price Action: GE shares are trading lower by 0.18% at $171.69 premarket at the last check Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Large Cap

Contracts

iShares Dow Jones US Aerospace & Defense Index Fund

Engine No. 1 ETF Trust Engine No. 1 Transform Climate ETF

NETZ

GE Aerospace Wins Orders From EVA Air And American Airlines: Details

Canaccord Genuity analyst Joseph Vafi maintains Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) with a Buy and raises the price target from $12 to $15.

IREN

Canaccord Genuity Maintains Buy on Iris Energy, Raises Price Target to $15

Needham analyst John Todaro maintains Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) with a Buy and lowers the price target from $15 to $13.

RIOT

Needham Maintains Buy on Riot Platforms, Lowers Price Target to $13

TMHC

Taylor Morrison Expects Q3 Home Closings To Be Approximately 3,200, Home Closings Gross Margin To Be Around 24%

MSGE

Madison Square Garden shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $41 to $45.

HC Wainwright &amp; Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) with a Buy and maintains $7 price target.

ANIX

HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $7 Price Target

DA Davidson analyst Linda Bolton Weiser maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Buy and maintains $191 price target.

DA Davidson Maintains Buy on Estee Lauder Cos, Maintains $191 Price Target

Goldman Sachs analyst Mark Delaney maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Neutral and lowers the price target from $248 to $230.

TSLA

Goldman Sachs Maintains Neutral on Tesla, Lowers Price Target to $230

Taylor Morrison Home Now Expects To Deliver 12,600 - 12,800 Homes This Year (Prior View 12,500) At Home Closings Gross Margin Around 24% (Prior View 23.5% - 24.0%)

RIVN

Rivian shares are trading lower after a report indicating the company will face a trial in a Tesla trade secrets theft case.

Vertiv Holdings shares are trading higher after the company reported better-than-expected Q2 EPS and sales. Additionally, the company raised its FY24 guidance.

2024 Outlook1
Otis is revising its full year outlook:
&nbsp;
<ul>
<li>Net sales of $14.3 billion to $14.5 billion</li>
<li>Organic sales up 1% to 3%
<ul>
<li>Organic New Equipment sales down mid-single digits</li>
<li>Organic Service sales up 6% to 7%</li>
</ul>
</li>
<li>Adjusted operating profit of $2.40 billion to $2.45 billion, up $160 million to $190 million at constant currency; up $135 million to $175 million at actual currency</li>
<li>Adjusted EPS of $3.85 to $3.90, up 9% to 10%; adjusted effective tax rate of approximately 25.25%</li>
<li>Adjusted free cash flow of approximately $1.5 billion to $1.6 billion</li>
</ul>

OTIS

Otis Worldwide Revises FY2024 Adj EPS Guidance from $3.83-3.90 To $3.85-$3.90 vs $3.87 Est; Lowers FY2024 Sales Guidance from $14.50B-$14.80B To $14.30B-$14.50B vs $14.62B Est

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) with a Buy and maintains $12 price target.

EYEN

HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

GERN

Geron shares are trading lower after the company announced the departure of CCO Anil Kapur.

Taylor Morrison Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMHC#NYSE">TMHC</a>) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $1.90 by 3.68 percent. This is a 7.08 percent decrease over earnings of $2.12 per share from the same period last year. The company reported quarterly sales of $1.991 billion which beat the analyst consensus estimate of $1.839 billion by 8.24 percent. This is a 3.40 percent decrease over sales of $2.061 billion the same period last year.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Alternaturals

News

Latest news for Alternaturals (OTC:ANAS) Stock